The Market Reports

Index

1 Pyelonephritis Drug Market Overview
1.1 Product Overview and Scope of Pyelonephritis Drug
1.2 Pyelonephritis Drug Segment by Type
1.2.1 Global Pyelonephritis Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Finafloxacin
1.2.3 Fosfomycin Tromethamine
1.2.4 Nacubactam
1.2.5 Plazomicin Sulfate
1.2.6 Others
1.3 Pyelonephritis Drug Segment by Application
1.3.1 Global Pyelonephritis Drug Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Pyelonephritis Drug Market Size Estimates and Forecasts
1.4.1 Global Pyelonephritis Drug Revenue 2016-2027
1.4.2 Global Pyelonephritis Drug Sales 2016-2027
1.4.3 Pyelonephritis Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Pyelonephritis Drug Market Competition by Manufacturers
2.1 Global Pyelonephritis Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pyelonephritis Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pyelonephritis Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pyelonephritis Drug Manufacturing Sites, Area Served, Product Type
2.5 Pyelonephritis Drug Market Competitive Situation and Trends
2.5.1 Pyelonephritis Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pyelonephritis Drug Players Market Share by Revenue
2.5.3 Global Pyelonephritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pyelonephritis Drug Retrospective Market Scenario by Region
3.1 Global Pyelonephritis Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pyelonephritis Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pyelonephritis Drug Market Facts & Figures by Country
3.3.1 North America Pyelonephritis Drug Sales by Country
3.3.2 North America Pyelonephritis Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pyelonephritis Drug Market Facts & Figures by Country
3.4.1 Europe Pyelonephritis Drug Sales by Country
3.4.2 Europe Pyelonephritis Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pyelonephritis Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Pyelonephritis Drug Sales by Region
3.5.2 Asia Pacific Pyelonephritis Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pyelonephritis Drug Market Facts & Figures by Country
3.6.1 Latin America Pyelonephritis Drug Sales by Country
3.6.2 Latin America Pyelonephritis Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pyelonephritis Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Pyelonephritis Drug Sales by Country
3.7.2 Middle East and Africa Pyelonephritis Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pyelonephritis Drug Historic Market Analysis by Type
4.1 Global Pyelonephritis Drug Sales Market Share by Type (2016-2021)
4.2 Global Pyelonephritis Drug Revenue Market Share by Type (2016-2021)
4.3 Global Pyelonephritis Drug Price by Type (2016-2021)

5 Global Pyelonephritis Drug Historic Market Analysis by Application
5.1 Global Pyelonephritis Drug Sales Market Share by Application (2016-2021)
5.2 Global Pyelonephritis Drug Revenue Market Share by Application (2016-2021)
5.3 Global Pyelonephritis Drug Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Achaogen Inc
6.1.1 Achaogen Inc Corporation Information
6.1.2 Achaogen Inc Description and Business Overview
6.1.3 Achaogen Inc Pyelonephritis Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Achaogen Inc Pyelonephritis Drug Product Portfolio
6.1.5 Achaogen Inc Recent Developments/Updates
6.2 AstraZeneca Plc
6.2.1 AstraZeneca Plc Corporation Information
6.2.2 AstraZeneca Plc Description and Business Overview
6.2.3 AstraZeneca Plc Pyelonephritis Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 AstraZeneca Plc Pyelonephritis Drug Product Portfolio
6.2.5 AstraZeneca Plc Recent Developments/Updates
6.3 Meiji Seika Pharma Co Ltd
6.3.1 Meiji Seika Pharma Co Ltd Corporation Information
6.3.2 Meiji Seika Pharma Co Ltd Description and Business Overview
6.3.3 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Product Portfolio
6.3.5 Meiji Seika Pharma Co Ltd Recent Developments/Updates
6.4 Merck & Co Inc
6.4.1 Merck & Co Inc Corporation Information
6.4.2 Merck & Co Inc Description and Business Overview
6.4.3 Merck & Co Inc Pyelonephritis Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck & Co Inc Pyelonephritis Drug Product Portfolio
6.4.5 Merck & Co Inc Recent Developments/Updates
6.5 MerLion Pharmaceuticals Pte Ltd
6.5.1 MerLion Pharmaceuticals Pte Ltd Corporation Information
6.5.2 MerLion Pharmaceuticals Pte Ltd Description and Business Overview
6.5.3 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Product Portfolio
6.5.5 MerLion Pharmaceuticals Pte Ltd Recent Developments/Updates
6.6 The Medicines Company
6.6.1 The Medicines Company Corporation Information
6.6.2 The Medicines Company Description and Business Overview
6.6.3 The Medicines Company Pyelonephritis Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 The Medicines Company Pyelonephritis Drug Product Portfolio
6.6.5 The Medicines Company Recent Developments/Updates
6.7 Zavante Therapeutics Inc
6.6.1 Zavante Therapeutics Inc Corporation Information
6.6.2 Zavante Therapeutics Inc Description and Business Overview
6.6.3 Zavante Therapeutics Inc Pyelonephritis Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Zavante Therapeutics Inc Pyelonephritis Drug Product Portfolio
6.7.5 Zavante Therapeutics Inc Recent Developments/Updates

7 Pyelonephritis Drug Manufacturing Cost Analysis
7.1 Pyelonephritis Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pyelonephritis Drug
7.4 Pyelonephritis Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pyelonephritis Drug Distributors List
8.3 Pyelonephritis Drug Customers

9 Pyelonephritis Drug Market Dynamics
9.1 Pyelonephritis Drug Industry Trends
9.2 Pyelonephritis Drug Growth Drivers
9.3 Pyelonephritis Drug Market Challenges
9.4 Pyelonephritis Drug Market Restraints

10 Global Market Forecast
10.1 Pyelonephritis Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pyelonephritis Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pyelonephritis Drug by Type (2022-2027)
10.2 Pyelonephritis Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pyelonephritis Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pyelonephritis Drug by Application (2022-2027)
10.3 Pyelonephritis Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pyelonephritis Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pyelonephritis Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Pyelonephritis Drug Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Pyelonephritis Drug Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Pyelonephritis Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Pyelonephritis Drug Covered in This Study
Table 5. Global Pyelonephritis Drug Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Pyelonephritis Drug Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Pyelonephritis Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Pyelonephritis Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Pyelonephritis Drug Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Pyelonephritis Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Pyelonephritis Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pyelonephritis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pyelonephritis Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pyelonephritis Drug Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Pyelonephritis Drug Sales Market Share by Region (2016-2021)
Table 17. Global Pyelonephritis Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Pyelonephritis Drug Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Pyelonephritis Drug Sales Market Share by Country (2016-2021)
Table 20. North America Pyelonephritis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Pyelonephritis Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Pyelonephritis Drug Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Pyelonephritis Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Pyelonephritis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Pyelonephritis Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Pyelonephritis Drug Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Pyelonephritis Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Pyelonephritis Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Pyelonephritis Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Pyelonephritis Drug Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Pyelonephritis Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Pyelonephritis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Pyelonephritis Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Pyelonephritis Drug Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Pyelonephritis Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Pyelonephritis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Pyelonephritis Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Pyelonephritis Drug Sales (K Pcs) by Type (2016-2021)
Table 39. Global Pyelonephritis Drug Sales Market Share by Type (2016-2021)
Table 40. Global Pyelonephritis Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Pyelonephritis Drug Revenue Share by Type (2016-2021)
Table 42. Global Pyelonephritis Drug Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Pyelonephritis Drug Sales (K Pcs) by Application (2016-2021)
Table 44. Global Pyelonephritis Drug Sales Market Share by Application (2016-2021)
Table 45. Global Pyelonephritis Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Pyelonephritis Drug Revenue Share by Application (2016-2021)
Table 47. Global Pyelonephritis Drug Price (USD/Pcs) by Application (2016-2021)
Table 48. Achaogen Inc Corporation Information
Table 49. Achaogen Inc Description and Business Overview
Table 50. Achaogen Inc Pyelonephritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Achaogen Inc Pyelonephritis Drug Product
Table 52. Achaogen Inc Recent Developments/Updates
Table 53. AstraZeneca Plc Corporation Information
Table 54. AstraZeneca Plc Description and Business Overview
Table 55. AstraZeneca Plc Pyelonephritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. AstraZeneca Plc Pyelonephritis Drug Product
Table 57. AstraZeneca Plc Recent Developments/Updates
Table 58. Meiji Seika Pharma Co Ltd Corporation Information
Table 59. Meiji Seika Pharma Co Ltd Description and Business Overview
Table 60. Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Meiji Seika Pharma Co Ltd Pyelonephritis Drug Product
Table 62. Meiji Seika Pharma Co Ltd Recent Developments/Updates
Table 63. Merck & Co Inc Corporation Information
Table 64. Merck & Co Inc Description and Business Overview
Table 65. Merck & Co Inc Pyelonephritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Merck & Co Inc Pyelonephritis Drug Product
Table 67. Merck & Co Inc Recent Developments/Updates
Table 68. MerLion Pharmaceuticals Pte Ltd Corporation Information
Table 69. MerLion Pharmaceuticals Pte Ltd Description and Business Overview
Table 70. MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Product
Table 72. MerLion Pharmaceuticals Pte Ltd Recent Developments/Updates
Table 73. The Medicines Company Corporation Information
Table 74. The Medicines Company Description and Business Overview
Table 75. The Medicines Company Pyelonephritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. The Medicines Company Pyelonephritis Drug Product
Table 77. The Medicines Company Recent Developments/Updates
Table 78. Zavante Therapeutics Inc Corporation Information
Table 79. Zavante Therapeutics Inc Description and Business Overview
Table 80. Zavante Therapeutics Inc Pyelonephritis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Zavante Therapeutics Inc Pyelonephritis Drug Product
Table 82. Zavante Therapeutics Inc Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Pyelonephritis Drug Distributors List
Table 86. Pyelonephritis Drug Customers List
Table 87. Pyelonephritis Drug Market Trends
Table 88. Pyelonephritis Drug Growth Drivers
Table 89. Pyelonephritis Drug Market Challenges
Table 90. Pyelonephritis Drug Market Restraints
Table 91. Global Pyelonephritis Drug Sales Forecast by Type (2022-2027) & (K Pcs)
Table 92. Global Pyelonephritis Drug Sales Market Share Forecast by Type (2022-2027)
Table 93. Global Pyelonephritis Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global Pyelonephritis Drug Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global Pyelonephritis Drug Sales Forecast by Application (2022-2027) & (K Pcs)
Table 96. Global Pyelonephritis Drug Sales Market Share Forecast by Application (2022-2027)
Table 97. Global Pyelonephritis Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global Pyelonephritis Drug Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global Pyelonephritis Drug Sales Forecast by Region (2022-2027) & (K Pcs)
Table 100. Global Pyelonephritis Drug Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Pyelonephritis Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Pyelonephritis Drug Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pyelonephritis Drug
Figure 2. Global Pyelonephritis Drug Market Share by Type in 2020 & 2027
Figure 3. Finafloxacin Product Picture
Figure 4. Fosfomycin Tromethamine Product Picture
Figure 5. Nacubactam Product Picture
Figure 6. Plazomicin Sulfate Product Picture
Figure 7. Others Product Picture
Figure 8. Global Pyelonephritis Drug Market Share by Application in 2020 & 2027
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Pyelonephritis Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pyelonephritis Drug Market Size 2016-2027 (US$ Million)
Figure 14. Global Pyelonephritis Drug Sales 2016-2027 (K Pcs)
Figure 15. Global Pyelonephritis Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Pyelonephritis Drug Sales Share by Manufacturers in 2020
Figure 17. Global Pyelonephritis Drug Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Pyelonephritis Drug Players: Market Share by Revenue in 2020
Figure 19. Pyelonephritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Pyelonephritis Drug Sales Market Share by Region (2016-2021)
Figure 21. Global Pyelonephritis Drug Sales Market Share by Region in 2020
Figure 22. Global Pyelonephritis Drug Revenue Market Share by Region (2016-2021)
Figure 23. Global Pyelonephritis Drug Revenue Market Share by Region in 2020
Figure 24. U.S. Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Pyelonephritis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Pyelonephritis Drug by Type (2016-2021)
Figure 49. Sales Market Share of Pyelonephritis Drug by Application (2016-2021)
Figure 50. Sales Market Share of Pyelonephritis Drug by Application in 2020
Figure 51. Revenue Share of Pyelonephritis Drug by Application (2016-2021)
Figure 52. Revenue Share of Pyelonephritis Drug by Application in 2020
Figure 53. Manufacturing Cost Structure of Pyelonephritis Drug
Figure 54. Manufacturing Process Analysis of Pyelonephritis Drug
Figure 55. Pyelonephritis Drug Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed